ArticleJournal for immunotherapy of cancer2024

Harmonization of tumor mutation burden testing with comprehensive genomic profiling assays: an IQN Path initiative.

Riziero Esposito Abate et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.